- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 21.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 21.59M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 21.27M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $53K |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $45K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.68M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.94M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.58M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $22.89M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $26.14M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $29.47M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $30.9M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $6.87M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.51M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $24.5M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $28.27M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $33.2M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $37.2M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.66M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.7M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.22M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.92M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.46M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.6M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.65M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.85M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $334K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $173K |